New Criteria Predict Treatment Success for Recurring Head and Neck Cancers
(Medical Xpress) -- Researchers at the Duke Cancer Institute and the University of Chicago have found a way to identify the one in four patients with recurring head and neck cancers who are most likely...
View ArticleStudy finds that combination therapy reduces pauses in breathing caused by OSA
According to new research that will be presented Saturday, June 11, at the 20th Anniversary Meeting of the American Academy of Dental Sleep Medicine (AADSM), the apnea-hypopnea index (AHI) in patients...
View ArticleNew drug adds to arsenal against AIDS
A new drug, rilpivirine, can add powerfully to the combination of medications used to control HIV for first-time patients, researchers conclude in Friday's issue of The Lancet.
View ArticleElevated cholesterol levels: Benefit of ezetimibe is not proven
Elevated blood cholesterol levels are regarded as a risk factor for heart attacks and other cardiovascular diseases. However, this does not necessarily mean that every cholesterol-lowering drug can...
View ArticleFinding pathways to cancer progression may lead to identification of targeted...
Researchers are working to discover how genes interact with each other to lead to cancer progression. This research is expected to lead the way toward the discovery of new targeted therapies against...
View ArticleNew treatment for kala azar, the most deadly parasitic disease after malaria
East Africa is fighting the worst kala azar outbreak in a decade. Collaboration across the region through the Leishmaniasis East Africa Platform (LEAP) has resulted in the development of a new...
View ArticleCombination therapy beneficial for head and neck skin carcinomas, study shows
Patients who have high-risk non-melanoma skin carcinomas of the head and neck may benefit from concomitant radiotherapy and chemotherapy, according to a UNC-led study. Their study is the first to...
View ArticleBreast tenderness in women getting combo hormone therapy associated with...
Post-menopausal women who experience new onset breast tenderness after starting combination hormone therapy may have an increased risk of breast cancer compared to women who don't experience breast...
View ArticleCommonly used 3-drug regimen for idiopathic pulmonary fibrosis found harmful
The National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, has stopped one arm of a three arm multi-center, clinical trial studying treatments for the...
View ArticleBreast tenderness linked to increased breast density
(Medical Xpress) -- Post-menopausal women who experience breast tenderness after starting combination hormone therapy have a higher risk of breast cancer than women who don't, a study by researchers...
View ArticleCombo hormone therapy has increased breast cancer risk over estrogen alone
The debate about using menopausal hormone therapies to relieve symptoms in post-menopausal women has been ongoing. Is the combination therapy of estrogen and progestin better or worse than just giving...
View ArticleEnhanced treatment of brain tumors
Glioblastoma is regarded as the most malignant form of brain tumor. In many cases, neurosurgeons are not able to remove such tumors completely because of the risk of destroying too much brain tissue in...
View ArticleDual HER2 blockade significantly extends progression-free survival
Adding pertuzumab to a combination of trastuzumab and docetaxel chemotherapy extended progression-free survival by a median of 6.1 months in patients with metastatic HER2-positive breast cancer...
View ArticleCombined asthma medication therapy shown to reduce attacks
A Henry Ford Hospital study has found that using two types of common asthma medications in combination reduces severe asthma attacks.
View Article'Test and Treat' model offers new strategy for eliminating malaria
As researchers work to eliminate malaria worldwide, new strategies are needed to find and treat individuals who have malaria, but show no signs of the disease. The prevalence of asymptomatic or...
View ArticleResearchers find sarcoma tumor immune response with combination therapy
A team of 18 researchers at Moffitt Cancer Center in Tampa, Fla., have found that treating high-risk, soft tissue sarcoma patients with a combination of implanted dendritic cells (immune system cells)...
View ArticleCombination treatment in mice shows promise for fatal neurological disorder...
Infants with Batten disease, a rare but fatal neurological disorder, appear healthy at birth. But within a few short years, the illness takes a heavy toll, leaving children blind, speechless and...
View ArticleScientists link two cancer-promoting pathways in esophageal cancer
Identification of a non-traditional pathway for spiriting a cancer-promoting protein into the cell nucleus points to a possible combination therapy for esophageal cancer and indicates a mechanism of...
View ArticleResearchers use dual strategy to fight Type 1 diabetes
(Medical Xpress) -- University of Florida researchers teamed with colleagues at City of Hope National Medical Center in Duarte, Calif., to devise a new combination therapy that reverses established...
View ArticleCombination antibiotic treatment does not result in less organ failure in...
Frank M. Brunkhorst, M.D., of Friedrich-Schiller University, Jena, Germany, and colleagues conducted a study to compare the effect of the antibiotics moxifloxacin and meropenem with the effect of...
View Article